ArticleCureus2026
Quercetin as a Natural Adjunct in Managing Plaque and Gingivitis in Adults: A Randomized Controlled Trial.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Gingivitis, a reversible inflammatory condition of the gingiva, is primarily caused by plaque accumulation. Chlorhexidine is the gold standard for plaque control, but it is associated with side effects on prolonged use. Quercetin, a natural flavonoid with antioxidant and anti-inflammatory properties, has shown promise in vitro, but clinical evidence remains limited. Aim To compare the effectiveness of quercetin mouthwash with chlorhexidine and placebo in reducing dental plaque accumulation and gingivitis. Materials and methods A triple-blind, randomized controlled trial was conducted among 45 dental students aged 18-27 years, who were allocated to three groups: Quercetin (2%), chlorhexidine (0.2%), and placebo mouthwash. Plaque Index and Gingival Index were recorded at baseline, 15 days, and 30 days. Statistical analysis was performed using repeated measures two-way ANOVA with a significance level of p ≤ 0.05. Results Both quercetin and chlorhexidine groups demonstrated a statistically significant reduction in Gingival Index scores from baseline to 30 days (p < 0.001) compared to placebo. Plaque scores remained minimal in both groups, with no significant difference between quercetin and chlorhexidine at 15 and 30 days. Mild tooth staining was observed in the chlorhexidine group, while quercetin showed no adverse effects. Conclusion Quercetin mouthwash demonstrated efficacy alternative to chlorhexidine in reducing gingival inflammation and controlling plaque within the limits of this exploratory trial, without associated side effects, making it a promising natural alternative for long-term use. However, as formal non-inferiority testing was not performed, these findings should be interpreted as preliminary.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.